Is VVOS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VVOS. It does not provide personalized investment advice.

VVOS (Vivos Therapeutics, Inc. Common Stock) Stock Analysis - Financials

Vivos Therapeutics, Inc. Common Stock (VVOS) is a publicly traded Healthcare sector company. As of September 8, 2026, VVOS trades at $0.18 with a market cap of $3.75M and a P/E ratio of -0.10. VVOS moved +0.00% today. Year to date, VVOS is -90.82%; over the trailing twelve months it is -95.48%. Its 52-week range spans $0.16 to $7.95. Analyst consensus is neutral with an average price target of $0.75. Rallies surfaces VVOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are VVOS's key financials?

VVOS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VVOS recently traded at $0.18. Market cap is $3.75M. P/E ratio is -0.10. Revenue is $20.90M.

VVOS Key Metrics

Key financial metrics for VVOS
Metric	Value
Price	$0.18
Market Cap	$3.75M
P/E Ratio	-0.10
EPS	$-1.90
Dividend Yield	0.00%
52-Week High	$7.95
52-Week Low	$0.16
Volume	296.19K
Avg Volume	0
Revenue (TTM)	$20.90M
Net Income	$-25.63M
Gross Margin	61.90%

VVOS Analyst Consensus

1 analysts cover VVOS: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.75.

Common questions about VVOS

What are VVOS's key financials?: VVOS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VVOS recently traded at $0.18. Market cap is $3.75M. P/E ratio is -0.10. Revenue is $20.90M.
Is VVOS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VVOS. It does not provide personalized investment advice.